v3.26.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from Operating Activities:      
Net loss $ (41,321) $ (3,189,205) $ (1,160,446)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 78,458 75,501 76,246
Allowance (recovery) of CECL - trade receivable, net   134,960 (159,509)
(Gain) loss on foreign currency transactions 36,675 (80,603) (18,762)
Gain on conversion of functional currency from US $ to GBP - MD Local     (80,887)
Loss on sale of assets   1,369 12
Gain on valuation of warrants (965,095) 493,274  
Gain on deconsolidation (174,792) (14,404)  
Non cash interest expense     (5,026)
Changes in deferred tax assets     10,835
Changes in operating assets and liabilities:      
Decrease in accounts receivables   9,374 935,537
(Increase) decrease in other receivables (14,019) 2,536 (2,051)
(Increase) decrease in prepaid expense 1,231 (107,295) 15,726
(Decrease) increase in accounts payable and accrued expenses (1,259) 113,976 (207,250)
(Decrease) increase in VAT and other tax payable (3,954) 4,424 (5,637)
(Decrease) increase in related party payable (3,272) 3,444  
(Decrease) increase in deferred income   (1,486) 1,847
Net Cash Used in Operating Activities (1,087,348) (1,060,717) (599,365)
Cash Flows from Investing Activities:      
Purchase of fixtures,office equipment and improvements (362,526) (35,748) (106,544)
Proceeds from disposal of assets     1,384
Loan repayment received     66,376
Cash disposed of from deconsolidation of VIE (119)    
Net Cash Used in Investing Activities (362,645) (35,748) (38,784)
Cash Flows from Financing Activities:      
Repayment of short term loans     (363,089)
Proceeds from private placement   2,450,002  
Costs of private placement   (256,500)  
Proceeds from exercise series warrants A and B 324,000 232,958  
Net Cash Provided by (Used in) Financing Activities 324,000 2,426,460 (363,089)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (362) (6,666) 71,585
Net (decrease) increase in cash, cash equivalents and restricted cash (1,126,355) 1,323,329 (929,653)
Cash, cash equivalents, and restricted cash - beginning of the period 1,826,834 503,505 1,433,158
Cash, cash equivalents, and restricted cash - end of the period 700,479 1,826,834 503,505
Cash and cash equivalents 700,479 1,826,641 499,654
Restricted foreign currency   193 3,851
Total cash, cash equivalents, and restricted cash 700,479 1,826,834 $ 503,505
Non-cash investing and financing activities      
Share-based compensation applied to construction in progress   50,925  
Reclassification of warrant liability to equity upon exercise of warrants $ 126,180    
Employees      
Adjustments to reconcile net loss to net cash used in operating activities:      
Share-based compensation   1,130,249  
Executive officers      
Adjustments to reconcile net loss to net cash used in operating activities:      
Share-based compensation   $ 363,169